Physician
Joe, Mary
Joe, Mary was paid $502K by Medicaid between Jan 2018 and Feb 2023, across 12 billing codes. Its largest line is S9083, Global fee urgent care centers — 82% of everything it billed.
33Billing provider infoJOE, MARY
LAWRENCE, MA 01843
LAWRENCE, MA 01843
33aNPI1063402659assigned 10/25/2005
33bProvider typeEmergency Medicine Physician
28Total paid$502K
24GClaims4,704
24DCodes billed12
24AFirst – last monthJan 2018 – Feb 2023
Compared with peers
Next to other Emergency Medicine Physician providers in Massachusetts
Rank by total paid#33 of 618
Median peer was paid$8K
This provider vs. median61×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 123 | $8K | |
| 2019 | 157 | $23K | |
| 2020 | 971 | $122K | |
| 2021 | 1,974 | $171K | |
| 2022 | 1,212 | $143K | |
| 2023 | 267 | $36K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| S9083 | Global fee urgent care centers | 82% | 3,182 | 3,102 | $409K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 10% | 361 | 348 | $51K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 3.0% | 129 | 128 | $15K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 1.4% | 163 | 162 | $7K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.1% | 37 | 37 | $6K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 83 | 81 | $4K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 169 | 166 | $4K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 28 | 28 | $2K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 44 | 44 | $2K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 12 | 12 | $1K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 244 | 235 | $300.00 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 252 | 243 | $10.50 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.